MET and neoplasm: In the morphoproteomic laboratory, the phospho-specific probe for tyrosine 1234/1235 was used to assess the state of phosphorylative activation of c-Met in Patient #1′s tumor cells; it detected 0 to 1+ (rare 2+) staining intensity on a scale of 0 to 3+.